BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,031 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,744,059 | -21.4% | 111,930 | +0.4% | 0.02% | -24.2% |
| Q1 2024 | $4,764,783 | +10.9% | 111,483 | +0.3% | 0.03% | +6.5% |
| Q4 2023 | $4,295,010 | +11.8% | 111,097 | +9.1% | 0.03% | -3.1% |
| Q3 2023 | $3,842,762 | -4.4% | 101,822 | +15.4% | 0.03% | +3.2% |
| Q2 2023 | $4,019,394 | +15.8% | 88,222 | +3.1% | 0.03% | +3.3% |
| Q1 2023 | $3,470,070 | +79800.3% | 85,554 | +0.4% | 0.03% | -18.9% |
| Q4 2022 | $4,343 | -99.9% | 85,214 | +15.7% | 0.04% | -7.5% |
| Q3 2022 | $3,967,000 | -15.8% | 73,663 | +0.5% | 0.04% | -20.0% |
| Q2 2022 | $4,709,000 | -9.4% | 73,314 | +9.4% | 0.05% | -2.0% |
| Q1 2022 | $5,195,000 | -3.7% | 66,994 | +6.6% | 0.05% | -10.5% |
| Q4 2021 | $5,395,000 | +7.1% | 62,846 | +0.3% | 0.06% | -3.4% |
| Q3 2021 | $5,039,000 | -0.7% | 62,647 | -0.6% | 0.06% | +3.5% |
| Q2 2021 | $5,072,000 | -4.8% | 63,002 | -0.3% | 0.06% | -13.6% |
| Q1 2021 | $5,328,000 | +4.0% | 63,172 | -1.0% | 0.07% | -8.3% |
| Q4 2020 | $5,122,000 | +35.8% | 63,828 | +36.1% | 0.07% | -2.7% |
| Q3 2020 | $3,772,000 | +50.6% | 46,905 | +61.2% | 0.07% | +60.9% |
| Q2 2020 | $2,505,000 | -5.4% | 29,096 | -10.8% | 0.05% | -23.3% |
| Q1 2020 | $2,648,000 | -3.7% | 32,618 | -0.8% | 0.06% | +25.0% |
| Q4 2019 | $2,749,000 | -3.9% | 32,878 | +0.5% | 0.05% | -5.9% |
| Q3 2019 | $2,862,000 | +25.5% | 32,716 | +17.5% | 0.05% | +30.8% |
| Q2 2019 | $2,281,000 | +0.7% | 27,854 | -0.0% | 0.04% | 0.0% |
| Q1 2019 | $2,266,000 | +27.5% | 27,867 | +3.2% | 0.04% | +11.4% |
| Q4 2018 | $1,777,000 | -43.5% | 26,998 | -33.8% | 0.04% | -20.5% |
| Q3 2018 | $3,143,000 | -17.5% | 40,773 | -20.9% | 0.04% | -13.7% |
| Q2 2018 | $3,808,000 | +31.7% | 51,571 | +16.0% | 0.05% | +27.5% |
| Q1 2018 | $2,892,000 | -0.2% | 44,466 | -0.8% | 0.04% | 0.0% |
| Q4 2017 | $2,898,000 | +13.3% | 44,839 | +10.0% | 0.04% | +5.3% |
| Q3 2017 | $2,558,000 | +16.6% | 40,768 | +12.5% | 0.04% | +11.8% |
| Q2 2017 | $2,194,000 | +17.3% | 36,238 | +0.5% | 0.03% | +6.2% |
| Q1 2017 | $1,870,000 | +50.3% | 36,056 | +28.5% | 0.03% | +39.1% |
| Q4 2016 | $1,244,000 | -6.5% | 28,062 | +0.4% | 0.02% | -11.5% |
| Q3 2016 | $1,331,000 | -33.4% | 27,957 | -36.8% | 0.03% | -29.7% |
| Q2 2016 | $2,000,000 | +19.8% | 44,218 | +8.8% | 0.04% | +2.8% |
| Q1 2016 | $1,670,000 | +22.5% | 40,657 | +13.8% | 0.04% | +24.1% |
| Q4 2015 | $1,363,000 | +18.4% | 35,740 | +2.0% | 0.03% | +7.4% |
| Q3 2015 | $1,151,000 | -73.1% | 35,051 | -42.6% | 0.03% | -65.4% |
| Q2 2015 | $4,274,000 | +0.2% | 61,116 | -1.8% | 0.08% | +2.6% |
| Q1 2015 | $4,264,000 | -41.2% | 62,245 | -37.1% | 0.08% | -29.0% |
| Q4 2014 | $7,248,000 | +1.7% | 98,890 | -0.5% | 0.11% | 0.0% |
| Q3 2014 | $7,130,000 | -0.8% | 99,342 | -0.0% | 0.11% | +1.9% |
| Q2 2014 | $7,185,000 | -6.2% | 99,379 | -4.5% | 0.10% | -11.0% |
| Q1 2014 | $7,657,000 | +6.3% | 104,070 | +0.5% | 0.12% | +3.5% |
| Q4 2013 | $7,204,000 | -1.1% | 103,584 | -6.6% | 0.11% | -5.8% |
| Q3 2013 | $7,282,000 | -4.7% | 110,853 | +0.5% | 0.12% | -8.3% |
| Q2 2013 | $7,644,000 | – | 110,353 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |